tyrosyl-glycyl-tryptophyl-methionyl-aspartyl-phenylalanyl-glycine has been researched along with Colonic Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baba, M; Itoh, K; Tatsuta, M | 1 |
| Boland, CR; DelValle, J; Dickinson, CJ; Kochman, ML | 1 |
2 other study(ies) available for tyrosyl-glycyl-tryptophyl-methionyl-aspartyl-phenylalanyl-glycine and Colonic Neoplasms
| Article | Year |
|---|---|
Glycine-extended gastrin induces matrix metalloproteinase-1- and -3-mediated invasion of human colon cancer cells through type I collagen gel and Matrigel.
Topics: Biocompatible Materials; Collagen; Collagen Type I; Colonic Neoplasms; DNA, Complementary; Drug Combinations; Gastrins; Gels; Humans; Laminin; Matrix Metalloproteinase 1; Matrix Metalloproteinase 3; Neoplasm Invasiveness; Proteoglycans; Transfection; Tumor Cells, Cultured | 2004 |
Post-translational processing of gastrin in neoplastic human colonic tissues.
Topics: Amino Acid Sequence; Colon; Colonic Neoplasms; Gastrins; Humans; Intestinal Mucosa; Molecular Sequence Data; Protein Precursors; Protein Processing, Post-Translational; Rectal Neoplasms; Tumor Cells, Cultured | 1992 |